Group One Trading’s Tectonic Therapeutic TECX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$961K Buy
31,100
+24,700
+386% +$608K ﹤0.01% 2763
2025
Q4
$134K Buy
+6,400
New +$119K ﹤0.01% 4743
2024
Q3
Sell
-47,000
Closed -$774K 7497
2024
Q2
$774K Buy
47,000
+43,033
+1,085% +$689K ﹤0.01% 2201
2024
Q1
$60.9K Buy
3,967
+3,900
+5,821% +$61.8K ﹤0.01% 4547
2023
Q4
$1.09K Sell
67
-808
-92% -$13.9K ﹤0.01% 6977
2023
Q3
$16.2K Buy
875
+342
+64% +$6.05K ﹤0.01% 6039
2023
Q2
$6.08K Buy
533
+66
+14% +$746 ﹤0.01% 6635
2023
Q1
$5.6K Buy
+467
New +$6.5K ﹤0.01% 6233
2022
Q3
Sell
-467
Closed -$5K 8376
2022
Q2
$5K Sell
467
-841
-64% -$9.91K ﹤0.01% 7146
2022
Q1
$21K Buy
1,308
+250
+24% +$5.17K ﹤0.01% 6728
2021
Q4
$49K Buy
1,058
+850
+409% +$48.8K ﹤0.01% 6358
2021
Q3
$14K Buy
208
+66
+46% +$5.42K ﹤0.01% 7364
2021
Q2
$15K Buy
142
+92
+184% +$10.9K ﹤0.01% 7357
2021
Q1
$8K Buy
+50
New +$8.13K ﹤0.01% 7135

Other funds holding TECX

Group One Trading's TECX Position: Q1 2026 in Review

Group One Trading sold out of Tectonic Therapeutic (TECX) in Q1 2026, closing a stake of 541 shares — an estimated $13.3K sold.

Group One Trading first reported a position in TECX in Q1 2021 and held it in 14 quarters. The position peaked at $355K in Q1 2021. 111 funds tracked by Wall St. Rank hold TECX as of Q1 2026.

  • Group One Trading reported no remaining Tectonic Therapeutic position as of Q1 2026 after selling out during the quarter.
  • Group One Trading sold 541 Tectonic Therapeutic shares in Q1 2026, an estimated $13.3K.
  • Group One Trading first reported a position in Tectonic Therapeutic in Q1 2021 and held it in 14 quarters.
  • Group One Trading's Tectonic Therapeutic position peaked at $355K in Q1 2021.
  • 111 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.